
pmid: 25829088
This article presents a review of multiple myeloma, precursor states, and related plasma cell disorders. The clinical roles of fluorodeoxyglucose PET/computed tomography (CT) and the potential to improve the management of patients with multiple myeloma are discussed. The clinical and research data supporting the utility of PET/CT use in evaluating myeloma and other plasma cell dyscrasias continues to grow.
Male, Paraproteinemias, Middle Aged, Multimodal Imaging, Fluorodeoxyglucose F18, Positron-Emission Tomography, Disease Progression, Humans, Female, Neoplasm Metastasis, Radiopharmaceuticals, Multiple Myeloma, Tomography, X-Ray Computed, Aged, Neoplasm Staging
Male, Paraproteinemias, Middle Aged, Multimodal Imaging, Fluorodeoxyglucose F18, Positron-Emission Tomography, Disease Progression, Humans, Female, Neoplasm Metastasis, Radiopharmaceuticals, Multiple Myeloma, Tomography, X-Ray Computed, Aged, Neoplasm Staging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
